Replies to post #472901 on Anavex Life Sciences Corp (AVXL)

[crescentmotor]

CM and Anavex had the ability to eliminate the risk and they didn't do it, so now they depend on a little luck to supplement that positives about 2-73.

That's true but hopefully the data will be seen as substantial enough to obtain provisional approval in Europe. After all, none of the MABs are approved in Europe due to a negative risk/benefit assessment. It seems to me that the EMA would be anxious to make a safe drug with at least some demonstration of efficacy available to the public as quickly as possible..